查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1190546

牙科骨基质市场——增长、趋势、COVID-19 的影响和预测 (2023-2028)

Dental Bone Graft Substitutes Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在 2022 年至 2027 年的预测期内，牙科骨替代材料市场预计将以 6.8% 的复合年增长率增长。

COVID-19 大流行正在影响世界各地的行业。 由于所有从事 COVID-19 管理的医疗机构只能获得基本护理，牙科诊所的临时关闭大大减少了牙科手术。 例如，美国牙科协会 (ADA) 已将选择性牙科护理推迟至 2020 年 4 月 6 日，并建议牙科诊所仅提供紧急牙科服务。 此外，在 2020 年 4 月 1 日的更新中，ADA 建议，由于 COVID-19 病例数量不断增加，至少在 4 月 30 日之前应避免非紧急和急救程序。增加。 结果，获得牙科保健的机会大大减少。 此外，2020 年 3 月，根据 ADA 健康政策研究所的一项调查，76% 的受访牙科诊所关闭且仅关闭急诊患者，19% 完全关闭，5% 开放，但患者数量很小 这就是我所说的。 这些因素严重影响了牙科骨替代品製造商及其供应链。 因此，这些统计数据表明，在 COVID-19 大流行期间，对牙科骨替代材料的需求有所下降。

此外，医疗和牙科旅游需求的增加、牙科疾病负担的增加以及牙科技术的进步是市场增长的主要驱动力。 牙科疾病负担的增加正在推动市场的增长。 例如，根据世界卫生组织（2020 年）的数据，口腔疾病影响了大约 35 亿人，据说超过 5.3 亿儿童的乳牙患有龋齿。

在植入种植体之前进行植骨以维持现有的颌骨，这有助于种植体手术的成功。 因此，在牙科手术中越来越多地使用这种合成和生物相容的植入物最终将引发市场增长。 2020 年 5 月发表的一项题为“全球牙周病患病率及其缺乏监测”的研究发现，牙周炎在老年人和高收入人群中最为常见。 低收入（28.7%）、中低收入（10%）、中高收入（42.5%）和高收入（43.7%）国家之间的分配差异很大。 此外，根据 International Dental Journal 论文“墨西哥成年人群中牙齿脱落的风险指标”，“墨西哥成年人群中牙齿缺失的风险指标。”2021 年 2 月发表的一项横断面研究。57.2% 的牙齿是在墨西哥因龋齿而失踪。 因此，由于上述因素，预计未来市场将出现显着增长。

此外，市场参与者的战略举措也在推动市场的增长。 例如，2022 年 4 月，Aspen Group 与骨再生产品供应商之一的 ACE Surgical Supply 就牙科植骨解决方案建立了多年战略合作伙伴关係。

因此，由于上述因素，市场预计在预测期内会出现增长。 然而，昂贵的牙科治疗和保险报销问题阻碍了市场增长。

主要市场趋势

异种移植部分预计在预测期内增长

按类型划分，异种移植部分预计将占据很大的市场份额。 异种移植是将器官或组织移植到另一个物种的个体中。 异种移植物是从猪 (pigs) 或牛 (bovines) 获得的，经过大量清洁和灭菌后准备用于人体植入。 脱蛋白牛骨是牙科中最常见的异种移植物来源。 市售的异种移植物包括 Bio-Oss、Bio-Oss 胶原蛋白和 Pepgen-P15。 由于异种移植是最便宜的，市场上的主要参与者都在努力推出新产品。

例如，2022 年 3 月，Fredun Pharmaceuticals Limited 获得印度中央药品标准控制组织 (CDSCO) 的批准，可以为一系列牙科和骨科手术器械製造异种移植物。 有了这个，该公司的目标是渗透到整个印度的牙科社区。 这些发展有望加速牙科骨替代品的发展，以取代异种移植物并促进该领域的发展。

此外，市场参与者的战略举措也为市场的增长做出了贡献。 例如，2021 年 9 月，Neos 与 Pergo Biologics 签署了一项协议，成为德国、瑞典和英国市场 Pergo Xenograft 牙种植体解决方案的主要合作伙伴和分销商。

因此，由于上述因素，预计该行业在预测期内将出现显着增长。

北美主导市场，预计在预测期内也会如此

牙科骨替代材料的全球市场预计将由北美主导。 在北美地区，美国有望占据较大的市场份额。 促进市场增长的主要因素是市场参与者采取的战略举措和牙科就诊次数的增加。

例如，根据疾病控制与预防中心 (CDC) 于 2021 年 1 月更新的数据，四分之一的 20-64 岁成年人至少有一颗蛀牙，大约 57% 的 12-64 岁青少年据说19年打了恆牙。 此外，根据 CDC（美国疾病控制与预防中心）2020 年 12 月的统计数据，超过四分之一的成年人 (26%) 有未经治疗的蛀牙，30 岁以上的成年人中约有一半 (46%) ) 显示出牙周病的迹象，严重的牙周病影响了美国大约 9% 的成年人。 据称，美国约有 9% 的成年人患有严重的牙周病。 根据这些统计数据，人们认为接受牙科护理的人口比例正在促进市场的增长。

此外，产品发布、批准、收购、合併、合作伙伴关係和合资企业等一系列战略举措有望促进该地区的增长，例如。 例如，2021 年 1 月，Dentsply Sirona 收购了以创新牙科修復产品而闻名的 Datum Dental Ltd.。 通过此次收购，登士柏西诺德在美国、加拿大和其他几个国家推广了完整的 OSSIX 产品组合，包括 OSSIX Plus、OSSIX Volumax 和 OSSIX Bone。

因此，由于上述因素，预计市场在预测期内将出现显着增长。

竞争格局

牙科骨替代品市场是一个竞争激烈的市场，在世界不同地区有多家公司。 从市场份额的角度来看，一些重要的参与者目前主导着市场。 随着患者意识水平的提高和牙科疾病的高患病率，预计许多区域参与者将在预测期内主导牙科骨替代品市场。 市场上的主要参与者包括 Dentsply Sirona、Johnson & Johnson、Institut Straumann AG、Medtronic PLC 和 ZIMMER BIOMET。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 对医疗、牙科和旅游的需求增加
    • 牙科疾病负担增加
    • 技术进步
  • 市场製约因素
    • 昂贵的牙科治疗
    • 保险报销问题
  • 产业吸引力 - 波特五力分析
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按类型
    • 异种移植
    • 同种异体移植
    • 自体移植
    • 其他类型
  • 按机制
    • 骨传导
    • 骨诱导（骨诱导
    • 骨骼形成
    • 促进骨质疏鬆
  • 最终用户
    • 医院
    • 牙科诊所
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东和非洲地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Dentsply Sirona
    • Johnson & Johnson
    • Institut Straumann AG
    • Medtronic PLC
    • ZIMMER BIOMET
    • Geistlich Pharm
    • Dentium
    • LifeNet Health
    • Collagen Matrix Inc.
    • Halma plc（Novabone LLC）
    • Botiss biomaterials GmbH
    • Wright Medical Group NV

第7章 市场机会今后动向

简介目录
Product Code: 72108

The dental bone graft substitutes market is expected to witness a CAGR of 6.8% over the forecast period, 2022-2027.

The COVID-19 pandemic has impacted industries worldwide. As all healthcare providers were engaged with COVID-19 management, access was restricted to essential care only, and the temporary closure of dental clinics drastically reduced dental surgeries. For instance, the American Dental Association (ADA) recommended that elective dental procedures be postponed until April 6, 2020, and dental practices should provide emergency-only dental services. Additionally, as per April 1, 2020, update, the ADA advised offices to remain closed to all but urgent and emergency procedures until April 30, at the earliest, owing to increasing COVID-19 cases. As a result, access to dental care was substantially decreased. Moreover, in March 2020, an ADA health policy institute survey indicated that 76% of dental offices surveyed were closed but seeing emergency patients only, 19% were completely closed, and 5% were open but seeing a lower volume of patients. These factors severely impacted dental bone graft substitute manufacturers and their supply chains. Thus, these statistics indicate that the demand for dental bone graft substitutes was reduced during the COVID-19 pandemic.

Furthermore, the significant factors responsible for the market's growth include the rising demand for medical and dental tourism; the increasing burden of dental diseases; and technological advancements in dentistry. The rising burden of dental diseases is driving the market's growth. For instance, according to the World Health Organization (2020), oral diseases affect nearly 3.5 billion people, and over 530 million children suffer from caries of their primary teeth.

To maintain the existing jaw, bone grafting is done before implant placement, which helps with successful implant surgery. Thus, increasing the use of such synthetic and biocompatible grafts in dental procedures ultimately triggers the market's growth. As per a May 2020 published study titled "Global Prevalence of Periodontal Disease and Lack of Its Surveillance," periodontitis was most common in older people and populations from high-income countries. The distribution varied significantly between low-income (28.7%), lower-middle (10%), upper-middle (42.5%), and high-income (43.7%) countries. Additionally, according to the International Dental Journal's article titled, "Risk Indicators of Tooth Loss among the Mexican Adult Population: A Cross-Sectional Study," published in February 2021, tooth loss was 57.2% due to tooth decay in Mexico. Hence, owing to the aforementioned factors, the market is expected to witness significant growth in the future.

Additionally, the strategic initiatives taken by the market players are also propelling the growth of the market. For instance, in April 2022, the Aspen Group and ACE Surgical Supply, one of the providers of bone regenerative products, signed a multi-year strategic partnership for dental bone grafting solutions.

Thus, owing to the abovementioned factors, the market is expected to show growth over the forecast period. However, expensive dental procedures and reimbursement issues hinder the market's growth.

Key Market Trends

The Xenogaft Segment is Expected to Grow Over the Forecast Period

The xenograft segment is expected to hold a significant market share by type. A xenograft is an organ transplant or a tissue graft to an individual of another species. Xenografts are obtained from pigs (porcine) or cows (bovine) and are prepared for implantation into the human body once thoroughly cleaned and sterilized. Deproteinized bovine bone is the most common source of xenograft materials in dentistry. A few commercially available xenografts are Bio-Oss, Bio-Oss Collagen, and Pepgen-P15, among others. As xenograft are most affordable, the key players in the market are taking initiatives to launch new products.

For instance, in March 2022, Fredun Pharmaceuticals Limited received approval to manufacture Xenografts for various dental and orthopedic surgical appliances from the Central Drugs Standard Control Organisation (CDSCO), India. With this, the company aims to penetrate the dental fraternity across India. Such developments are expected to fuel the development of dental bone graft substitutes for xenografts, thereby boosting the segment's growth.

Additionally, the strategic initiatives taken by the market players are also contributing to the growth of the market. For instance, in September 2021, Neoss signed an agreement with Purgo Biologics and became a key partner and distributor of the Purgo Xenograft product range for dental implant solutions in the German, Swedish, and United Kingdom markets.

Thus, the segment is expected to witness significant growth over the forecast period due to the abovementioned factors.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the global dental bone graft substitutes market. United States is likely to hold a significant market share in the North American region. The major factors contributing to the market's growth are strategic initiatives undertaken by the market players and the growing number of dental visits.

For instance, according to the Centers for Disease Control and Prevention (CDC) data updated in January 2021, 1 in 4 adults between 20-64 years of age suffer from at least one cavity, and almost 57% of adolescents aged 12-19 have had a hole in their permanent teeth. Also, as per December 2020 statistics by the Centers for Disease Control and Prevention (CDC), more than 1 in 4 (26%) adults have untreated tooth decay, and nearly half (46%) of all adults aged 30 years or older show signs of gum disease; and severe gum disease affects about 9% of adults in United States. These statistics indicate that the percentage of the population visiting dental clinics for examinations contributes to the market's growth.

Moreover, the growing number of strategic initiatives such as product launches, approvals, acquisitions, mergers, partnerships, and joint ventures are anticipated to boost regional growth. For instance, Dentsply Sirona acquired Datum Dental Ltd., known for innovative dental regeneration products, in January 2021. With this acquisition, Dentsply Sirona promotes the complete OSSIX portfolio, including OSSIX Plus, OSSIX Volumax, and OSSIX Bone, in United States, Canada, and several other countries.

Thus, the market is expected to witness significant growth over the forecast period due to the abovementioned factors.

Competitive Landscape

The dental bone graft substitutes market is highly competitive, with several players worldwide. In terms of market share, few significant players currently dominate the market. With the rising patient awareness levels and high prevalence of dental disorders, many regional players are expected to be part of the dental bone graft substitute market over the forecast period. Some of the market's major players are Dentsply Sirona, Johnson & Johnson, Institut Straumann AG, Medtronic PLC, ZIMMER BIOMET, etc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Demand of Medical and Dental Tourism
    • 4.2.2 Rising Burden of Dental Diseases
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Expensive Dental Procedures
    • 4.3.2 Reimbursement Issues
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Buyers/Consumers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Xenograft
    • 5.1.2 Allograft
    • 5.1.3 Autograft
    • 5.1.4 Other Types
  • 5.2 By Mechanism
    • 5.2.1 Osteoconduction
    • 5.2.2 Osteoinduction
    • 5.2.3 Osteogenesis
    • 5.2.4 Osteopromotion
  • 5.3 By End Users
    • 5.3.1 Hospitals
    • 5.3.2 Dental Clinics
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Dentsply Sirona
    • 6.1.2 Johnson & Johnson
    • 6.1.3 Institut Straumann AG
    • 6.1.4 Medtronic PLC
    • 6.1.5 ZIMMER BIOMET
    • 6.1.6 Geistlich Pharm
    • 6.1.7 Dentium
    • 6.1.8 LifeNet Health
    • 6.1.9 Collagen Matrix Inc.
    • 6.1.10 Halma plc (Novabone LLC)
    • 6.1.11 Botiss biomaterials GmbH
    • 6.1.12 Wright Medical Group NV

7 MARKET OPPORTUNITIES AND FUTURE TRENDS